These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 352778)

  • 1. [Prostaglandins. II. Therapeutic use in cardiovascular pathology].
    Innecco Urbani A; Maragno I
    G Ital Cardiol; 1978 May; 8(5):568-73. PubMed ID: 352778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects for the use of prostaglandins in pediatric cardiology].
    Zaorska B
    Kardiol Pol; 1981; 24(2):167-72. PubMed ID: 6788996
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of exogenous prostaglandins on the cardiovascular system].
    Alekseeva NP; Makoeva LD
    Sov Med; 1980; (2):96-101. PubMed ID: 6987749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of prostaglandins in arterial occlusive diseases].
    Diehm C
    Internist (Berl); 1994 Aug; 35(8):764-70; discussion 771-2. PubMed ID: 7960555
    [No Abstract]   [Full Text] [Related]  

  • 5. Substances with vasoactive effects mediated by the prostaglandin system.
    Pallapies D; Peskar BA
    Vasa Suppl; 1991; 33():75-6. PubMed ID: 1788770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible aspects of the use of prostacyclin, prostaglandin E1 and their synthetic analogs in medical practice].
    Petrukhina GN; Makarov VA
    Eksp Klin Farmakol; 1995; 58(3):70-9. PubMed ID: 7663307
    [No Abstract]   [Full Text] [Related]  

  • 7. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostacyclins, their synthetic analogs and the factors affecting their biosynthesis and release].
    Brus R
    Pol Tyg Lek; 1983 Aug; 38(35):1087-90. PubMed ID: 6366774
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patent ductus arteriosus.
    Friedman WF; Fitzpatrick KM; Merritt TA; Feldman BH
    Clin Perinatol; 1978 Sep; 5(2):411-36. PubMed ID: 371899
    [No Abstract]   [Full Text] [Related]  

  • 11. The prostaglandins: an introduction.
    Adams DR; Domínguez JN; Gómez LF
    Acta Cient Venez; 1982; 33(4):280-93. PubMed ID: 6764706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostaglandins in transfusion science (experimental research)].
    Glants RM
    Gematol Transfuziol; 1985 Jan; 30(1):3-7. PubMed ID: 3920115
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 14. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
    Heymann MA; Rudolph AM
    Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in the reaction of the embryonic myocardium to adrenaline and noradrenaline under the action of prostaglandins].
    Boroian RG
    Zh Eksp Klin Med; 1978; 18(1):20-3. PubMed ID: 645296
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin analogs as inhibitors of tumor cell DNA synthesis.
    Honn KV; Romine M; Skoff A
    Proc Soc Exp Biol Med; 1981 Apr; 166(4):562-7. PubMed ID: 7220548
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins in disease.
    Horton EW
    Practitioner; 1977 Apr; 218(1306):546-9. PubMed ID: 859800
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostaglandins. 2: Effect on several organ systems and clinical significance].
    Greven J
    Med Klin; 1979 Apr; 74(16):597-601. PubMed ID: 379561
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine mechanisms in the pathogenesis of essential hypertension. II. Interference of prostaglandins with the blood pressure elevating and lowering systems.
    Păuşescu E
    Physiologie; 1980; 17(2):127-37. PubMed ID: 6770384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.